Group items tagged

Published 01 May 2014 ACETO has announced that its wholly-owned subsidiary, Rising Pharmaceutical, has closed the acquisition of 100% of the equity interests of PACK Pharmaceuticals, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products. The total transaction value is approximately $100m.

In the present time, the pharmaceutical industry is attracting many young and dynamic professionals as it offers lots of opportunities for their shining careers.

PBR Staff Writer Published 20 March 2014 Ireland-based specialty pharmaceutical firm Actavis has entered into an agreement with Noven Pharmaceuticals to settle all outstanding patent litigation related to its generic version of Daytrana (Methylphenidate Transdermal System). Daytrana is a CNS stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.

Novartis has acquired CoStim Pharmaceuticals, an immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.

RainTree Oncology Services and Information Builders have launched OncoExplorer, a new cloud-based analytics portal that offers unprecedented decision-support capabilities to pharmaceutical companies.

The current competitive environment demands tactful management of most respected and skilled physicians by the healthcare organisations. Hence each healthcare organisation is making an ardent effort to ensure that no stone remains untouched. The fact of matter is not only true for the health care industry, but also for pharmaceutical companies.

The field of PCD Pharma suppliers is a vital part of the medical industry through the healthcare products are supplied to the different sources of the medical field.

Israel-based clinical-stage pharmaceutical firm Oramed Pharmaceuticals has received its third patent in Australia for oral administration of exenatide from the Australian government's patent office 'IP Australia'.

This report summary is an overview of the full report published by Best Practices, LLC. The report includes insights and information about the new pharmaceutical drugs launch spend in medical affairs in the US market.

Annair is a manufacturer & industrial suppliers.they provide customized services to the clients.they are leading air dryer manufacturers in India. ANNAIR Dryers & Chillers have been performing excellently already at over 1000 finders installations for the last 10 Years in India and abroad in various industrial sectors e.g., Foods & Beverages, Pharmaceuticals, Automotive, cement, chemical, manufacturing etc.

We are a leading Manufacturer & Supplier of Flip Top Caps such as Flip Top Caps 19MM, Mushroom Bottle Caps, Flip Top Cap - Simple 19mm, Flip Top Cap 25mm and Flip Top Cap 28mm from India. Rutvik Pharma Has Been in Plastic Packaging Industries For Over 10 Years & Has Emerged as Leader in Creating Total Packaging Solution For Healthcare, Chemical, Food & Beverage, Consumer Goods, Pharmaceutical Fmcg Lubricant Industries & Pesticide Industry.

Pharma Lab equipment, instruments Manufacturer, Exporter, Suppliers of mini models for r&d labs, main motor drives, universal gear for all purpose, coating, filling & dosing equipments, granulating, grinding attachments, homogenizing attachments, kneading attachments, mixing attachments, pelletizing attachments, sieves analysis attachments, stirring attachments, friability tester, single punch mini tablet press, rotary tablet press mini model, dies and punches, rapid mixer granulator, mini fluid bed unit, capsul filling, colloid mill - Ahmedabad, Gujarat, India.

US-based Spectrum Pharmaceuticals has announced that its new drug application (NDA) for Beleodaq has been accepted for filing by the FDA

US-based BioMarin Pharmaceutical has selected a new drug development candidate, BMN 250, for the treatment of Sanfilippo B syndrome or Mucopolysaccharidosis type IIIB (MPS IIIB).

Chindex International has entered into a definitive merger agreement with a buyer consortium of an affiliate of TPG, an affiliate of Shanghai Fosun Pharmaceutical (Group)

PBR Staff Writer Published 24 February 2014 US-based biotechnology firm Vertex Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) of its Kalydeco (ivacaftor) for the treatment of people with cystic fibrosis (CF).

US-based Edison Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for its lead drug EPI-743 to treat patients with Friedreich's ataxia.

Teva Pharmaceutical Industries has launched the generic equivalent to Xeloda tablets, 150mg and 500mg, in the US.

Germany-based pharmaceutical firm Boehringer Ingelheim has received approval from the US Food and Drug Administration (FDA) for Pradaxa (dabigatran etexilate) to treat venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE).